John F Mauldin - Net Worth and Insider Trading
John F Mauldin Net Worth
The estimated net worth of John F Mauldin is at least $59,855 dollars as of 2024-06-08. John F Mauldin is the Director of Galectin Therapeutics Inc and owns about 23,021 shares of Galectin Therapeutics Inc (GALT) stock worth over $59,855. Details can be seen in John F Mauldin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John F Mauldin has not made any transactions after 2014-01-02 and currently still holds the listed stock(s).
Transaction Summary of John F Mauldin
John F Mauldin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John F Mauldin owns 2 companies in total, including AgeX Therapeutics Inc (AGE) , and Galectin Therapeutics Inc (GALT) .
Click here to see the complete history of John F Mauldin’s form 4 insider trades.
Insider Ownership Summary of John F Mauldin
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AGE | AgeX Therapeutics Inc | 2018-11-27 | director |
GALT | Galectin Therapeutics Inc | 2014-01-02 | director |
John F Mauldin Latest Holdings Summary
John F Mauldin currently owns a total of 1 stock. John F Mauldin owns 23,021 shares of Galectin Therapeutics Inc (GALT) as of January 2, 2014, with a value of $59,855.
Latest Holdings of John F Mauldin
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GALT | Galectin Therapeutics Inc | 2014-01-02 | 23,021 | 2.60 | 59,855 |
Holding Weightings of John F Mauldin
John F Mauldin Form 4 Trading Tracker
According to the SEC Form 4 filings, John F Mauldin has made a total of 0 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years. The most-recent trade in Galectin Therapeutics Inc is the acquisition of 618 shares on January 2, 2014, which cost John F Mauldin around $4,950.
Insider Trading History of John F Mauldin
- 1
John F Mauldin Trading Performance
GuruFocus tracks the stock performance after each of John F Mauldin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John F Mauldin is 71.94%. GuruFocus also compares John F Mauldin's trading performance to market benchmark return within the same time period. The performance of stocks bought by John F Mauldin within 3 months outperforms 8 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John F Mauldin's insider trading performs compared to the benchmark.
Performance of John F Mauldin
John F Mauldin Ownership Network
Ownership Network List of John F Mauldin
Ownership Network Relation of John F Mauldin
John F Mauldin Owned Company Details
What does AgeX Therapeutics Inc do?
Who are the key executives at AgeX Therapeutics Inc?
John F Mauldin is the director of AgeX Therapeutics Inc. Other key executives at AgeX Therapeutics Inc include director & 10 percent owner Juvenescence Us Corp. , Chief Financial Officer Park Andrea Eun Jae , and director & Chief Executive Officer Michael D West .
AgeX Therapeutics Inc (AGE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AgeX Therapeutics Inc (AGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AgeX Therapeutics Inc (AGE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AgeX Therapeutics Inc (AGE)'s detailed insider trading history can be found in Insider Trading Tracker table.
AgeX Therapeutics Inc Insider Transactions
John F Mauldin Mailing Address
Above is the net worth, insider trading, and ownership report for John F Mauldin. You might contact John F Mauldin via mailing address: 3204 Beverly Drive, Dallas Tx 75205.